Abstract
Background: Drugs are related with various adverse drug reactions (ADRs), however, many unexpected ADRs of drugs are reported through post-marketing surveillance.
Aim: The current study's goal is to uncover potential signals connected with FDA-approved medications in the United States (2013).
Methods: Open Vigil 2.1-MedDRA-v24 (data 20004Q1-2021Q3) was used as a tool to query the FAERS data. To find possible signals, disproportionality measures such as Proportional Reporting Ratio (PRR 2) with associated Chi-square value, Reporting Odds Ratio (ROR 2) with 95% confidence interval, and case count (3) were calculated.
Results: A total of eight potential signals were identified with five drugs. Positive signals were found with pomalidomide, canagliflozin, dolutegravir sodium, macitentan and ibrutinib.
Conclusion: However, further causality assessment is required to confirm the association of these drugs with identified potential signals.
Graphical Abstract
[http://dx.doi.org/10.2165/00002018-199921060-00001] [PMID: 10612268]
[http://dx.doi.org/10.1007/s00228-008-0475-9] [PMID: 18523760]
[http://dx.doi.org/10.1371/journal.pone.0157753] [PMID: 27326858]
[http://dx.doi.org/10.3389/fphar.2020.00964] [PMID: 32848722]
[http://dx.doi.org/10.1007/s40264-020-00911-w] [PMID: 32008183]
[http://dx.doi.org/10.1111/bcp.14868] [PMID: 33871897]
[http://dx.doi.org/10.1002/jmv.28671] [PMID: 36916721]
[http://dx.doi.org/10.1080/14740338.2023.2189698] [PMID: 36888736]
[http://dx.doi.org/10.2174/1574886318666230228142856] [PMID: 36852785]
[http://dx.doi.org/10.1111/ane.13690] [PMID: 36029138]
[http://dx.doi.org/10.3389/fphar.2021.766125] [PMID: 34987394]
[http://dx.doi.org/10.4103/0976-0105.160753] [PMID: 26229348]
[http://dx.doi.org/10.1002/pds.5313]
[http://dx.doi.org/10.1016/j.nefro.2021.07.015] [PMID: 36437200]
[http://dx.doi.org/10.1177/2050313X221079444] [PMID: 35223037]